BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32555746)

  • 1. Feasibility of intratumoral 165Holmium siloxane delivery to induced U87 glioblastoma in a large animal model, the Yucatan minipig.
    Khoshnevis M; Carozzo C; Brown R; Bardiès M; Bonnefont-Rebeix C; Belluco S; Nennig C; Marcon L; Tillement O; Gehan H; Louis C; Zahi I; Buronfosse T; Roger T; Ponce F
    PLoS One; 2020; 15(6):e0234772. PubMed ID: 32555746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of
    Khoshnevis M; Brown R; Belluco S; Zahi I; Maciocco L; Bonnefont-Rebeix C; Pillet-Michelland E; Tranel J; Roger T; Nennig C; Oudoire P; Marcon L; Tillement O; Louis C; Gehan H; Bardiès M; Mariani M; Muzio V; Meunier JP; Duchemin C; Michel N; N'Tsiba E; Haddad F; Buronfosse T; Carozzo C; Ponce F
    Front Oncol; 2022; 12():923679. PubMed ID: 36419904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of induced glioblastoma by implantation of a human xenograft in Yucatan minipig as a large animal model.
    Khoshnevis M; Carozzo C; Bonnefont-Rebeix C; Belluco S; Leveneur O; Chuzel T; Pillet-Michelland E; Dreyfus M; Roger T; Berger F; Ponce F
    J Neurosci Methods; 2017 Apr; 282():61-68. PubMed ID: 28284687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation.
    Park SS; Chunta JL; Robertson JM; Martinez AA; Oliver Wong CY; Amin M; Wilson GD; Marples B
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):885-92. PubMed ID: 21489704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study.
    Stegen B; Nieto A; Albrecht V; Maas J; Orth M; Neumaier K; Reinhardt S; Weick-Kleemann M; Goetz W; Reinhart M; Parodi K; Belka C; Niyazi M; Lauber K
    Radiat Oncol; 2020 Jan; 15(1):19. PubMed ID: 31969174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy.
    Schwartz RB; Holman BL; Polak JF; Garada BM; Schwartz MS; Folkerth R; Carvalho PA; Loeffler JS; Shrieve DC; Black PM; Alexander E
    J Neurosurg; 1998 Jul; 89(1):60-8. PubMed ID: 9647173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
    Duma CM; Kim BS; Chen PV; Plunkett ME; Mackintosh R; Mathews MS; Casserly RM; Mendez GA; Furman DJ; Smith G; Oh N; Caraway CA; Sanathara AR; Dillman RO; Riley AS; Weiland D; Stemler L; Cannell R; Abrams DA; Smith A; Owen CM; Eisenberg B; Brant-Zawadzki M
    J Neurosurg; 2016 Dec; 125(Suppl 1):40-49. PubMed ID: 27903197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial.
    Smits ML; Nijsen JF; van den Bosch MA; Lam MG; Vente MA; Huijbregts JE; van het Schip AD; Elschot M; Bult W; de Jong HW; Meulenhoff PC; Zonnenberg BA
    J Exp Clin Cancer Res; 2010 Jun; 29(1):70. PubMed ID: 20550679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin glue system for adjuvant brachytherapy of brain tumors with 188Re and 186Re-labeled microspheres.
    Häfeli UO; Pauer GJ; Unnithan J; Prayson RA
    Eur J Pharm Biopharm; 2007 Mar; 65(3):282-8. PubMed ID: 17129715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical feasibility of [
    Verhoeven J; Bolcaen J; De Meulenaere V; Kersemans K; Descamps B; Donche S; Van den Broecke C; Boterberg T; Kalala JP; Deblaere K; Vanhove C; De Vos F; Goethals I
    Radiat Oncol; 2019 May; 14(1):89. PubMed ID: 31146757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.
    Dhermain F
    Chin J Cancer; 2014 Jan; 33(1):16-24. PubMed ID: 24384237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.
    Jablonska PA; Diez-Valle R; Pérez-Larraya JG; Moreno-Jiménez M; Idoate MÁ; Arbea L; Tejada S; Garcia de Eulate MR; Ramos L; Arbizu J; Domínguez P; Aristu JJ
    PLoS One; 2019; 14(6):e0217881. PubMed ID: 31170245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma.
    Kim MM; Parmar HA; Aryal MP; Mayo CS; Balter JM; Lawrence TS; Cao Y
    Tomography; 2019 Mar; 5(1):118-126. PubMed ID: 30854449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).
    Oehlke O; Mix M; Graf E; Schimek-Jasch T; Nestle U; Götz I; Schneider-Fuchs S; Weyerbrock A; Mader I; Baumert BG; Short SC; Meyer PT; Weber WA; Grosu AL
    BMC Cancer; 2016 Oct; 16(1):769. PubMed ID: 27716184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial Results of a Phase 2 Trial of
    Laack NN; Pafundi D; Anderson SK; Kaufmann T; Lowe V; Hunt C; Vogen D; Yan E; Sarkaria J; Brown P; Kizilbash S; Uhm J; Ruff M; Zakhary M; Zhang Y; Seaberg M; Wan Chan Tseung HS; Kabat B; Kemp B; Brinkmann D
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1383-1395. PubMed ID: 33771703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
    Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
    Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody.
    Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X
    Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator.
    Bolcaen J; Descamps B; Boterberg T; Vanhove C; Goethals I
    J Vis Exp; 2017 Dec; (130):. PubMed ID: 29364211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
    Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
    J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.